TJ has been involved with rare disease treatments through various roles in the pharmaceutical industry over the last 25 years.  She has held commercial and operational leadership positions in the UK as well as Global positions based out of Switzerland.  From 2015-2019 she was involved in planning the international launch of nusinersen and subsequently the geographic expansion across Europe and international markets.

TJ is strongly drawn towards the SMA community through what she has learned through meeting with families, physicians and healthcare teams.  She has not been a Trustee before and is looking forward to becoming a helpful member of the team.